Efficacy of Pergoveris in Aged IVF Patients

• Status: Completed
• Trial end date: 2014-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

To compare the efficacy between LH supplementation (Pergoveris) and non-LH supplementation (Follitropin alpha) in patients aged ≥ 35 years undergoing IVF treatment.

Study hypothesis: Pergoveris (LH supplementation) is better than follitropin alpha (non-LH supplementation) for ovarian stimulation in aged IVF patients.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Vietnam National University
• Treatments: Follicle Stimulating Hormone

Criteria

Inclusion Criteria:

• age ≥ 35 years

• body mass index <28 kg/m2

• had ≤ 3 previous IVF attempts

• receiving a GnRH-antagonist protocol

• agreement to participate in the study, and to disclose any medical events to the investigator. The subject must be willing and able to comply with the protocol requirements for the duration of the study.

• have given written informed consent with the understanding that the subject may withdraw consent at any time

Exclusion Criteria:

• participating in another interventional clinical trial

• PCOS or WHO group 1

• have uterine abnormalities

• have endocrine disorders such as hyperprolactinemia, thyroid disorders